SQI Diagnostics, Inc. (TSX-V: SQD; OTCQB: SQIDF) is a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare providers, patients, and consumers worldwide. The Company’s proprietary advanced diagnostics target organ transplant, autoimmune disease and COVID-19 testing which include the developmental direct-to-consumer COVID-19 HOME Antibody Test, the RALI-dx™ COVID-19 Severity Triage Test and the COVID-19 RALI-fast™ Severity Triage Point-of-Care (POC) Test.
Looking for a particular SQI Diagnostics employee's phone or email?
The SQI Diagnostics annual revenue was $29.3 million in 2026.
Morlan Reddock is the CFO & VP Investor Relations of SQI Diagnostics.
21 people are employed at SQI Diagnostics.
SQI Diagnostics is based in Toronto, Ontario.
The NAICS codes for SQI Diagnostics are [3254, 62151, 6215, 325413, 62, 325, 32, 621, 32541].
The SIC codes for SQI Diagnostics are [801, 80].